Ablynx Banks $200M IPO in Nasdaq Debut Post author:Sam Post published:October 24, 2017 Post category:BioPharma Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace You Might Also Like Effective Today: Cancer Biotech ImMAGE Shutters Operations August 31, 2017 Incoming MassBio Chairman Eyes Improving Gender Diversity Across the State’s Life Sciences Industry February 26, 2018 3 Biotechs With the Biggest and Most Promising Pipelines February 15, 2017
Incoming MassBio Chairman Eyes Improving Gender Diversity Across the State’s Life Sciences Industry February 26, 2018
